Posted by psychobot5000 on January 19, 2009, at 15:08:49
In reply to Re: Atypical APs with lowest SRI - for AD augment » psychobot5000, posted by SLS on January 18, 2009, at 17:34:02
I sure appreciate the complement, Scott! Some other posters, like Marty, helped lead me down this line of thought.
For what it's worth, when I read on the same subject maybe three or four years ago, there didn't seem to be all that much research interest on 5ht2c for mood disorders--even though its supposed potential, anxiolytic qualities, improved sleep, increased frontal cortex dopamine, all seemed to mark it as a potential treatment pathway. But when I read now, it seems like the interest in the field has caught up with its hypothesized potential--there's definitely more talk about it going on, from what I'm finding. Hopefully some of these new agents that target 2c and other 5ht2 receptors pan out for a substantial portion of patients.
Be well,
Psychbot
poster:psychobot5000
thread:874727
URL: http://www.dr-bob.org/babble/20090104/msgs/874981.html